TLQP-21 vs Xenopsin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
TLQP-21 is a 21-amino acid peptide derived from the C-terminal region of VGF (Nerve Growth Factor-Inducible), a large precursor neuropeptide that is proteolytically cleaved into multiple bioactive fragments. VGF is strongly induced by NGF and BDNF and plays roles in energy homeos...
Calculate TLQP-21 dose →Xenopsin is an octapeptide originally isolated from the skin of the South African clawed frog Xenopus laevis. It shares structural similarity with the C-terminal portion of neurotensin and activates neurotensin receptors....
Calculate Xenopsin dose →| Parameter | TLQP-21 | Xenopsin |
|---|---|---|
| Category | Neuropeptide | Neuropeptide |
| Research | Research | Preclinical |
| Half-Life | Unknown | Short |
| Typical Dose | 1-100 nmol (animal) | N/A (research) |
| Frequency | Variable | N/A |
| Route | Intrathecal, Subcutaneous, Intracerebroventricular | IV / ICV (research) |
| FDA Status | Not approved | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.